Tokio Marine Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6M Buy
65,800
+3,154
+5% +$679K 0.51% 35
2026
Q1
$13.6M Buy
62,646
+1,161
+2% +$258K 0.49% 34
2025
Q4
$14M Buy
61,485
+2,394
+4% +$545K 0.48% 34
2025
Q3
$13.7M Buy
59,091
+1,400
+2% +$285K 0.49% 36
2025
Q2
$10.7M Buy
57,691
+2,926
+5% +$544K 0.41% 43
2025
Q1
$11.5M Buy
54,765
+2,626
+5% +$511K 0.42% 47
2024
Q4
$9.27M Buy
52,139
+2,020
+4% +$371K 0.33% 62
2024
Q3
$9.9M Buy
50,119
+3,304
+7% +$617K 0.43% 48
2024
Q2
$8.03M Buy
46,815
+2,119
+5% +$351K 0.38% 50
2024
Q1
$8.14M Buy
44,696
+3,912
+10% +$674K 0.41% 51
2023
Q4
$6.32M Buy
40,784
+1,893
+5% +$276K 0.35% 56
2023
Q3
$5.8M Buy
38,891
+2,388
+7% +$351K 0.37% 59
2023
Q2
$4.92M Buy
36,503
+1,971
+6% +$289K 0.31% 59
2023
Q1
$5.5M Buy
34,532
+4,173
+14% +$638K 0.38% 56
2022
Q4
$4.91M Buy
30,359
+2,830
+10% +$434K 0.38% 59
2022
Q3
$3.69M Buy
27,529
+2,551
+10% +$366K 0.31% 58
2022
Q2
$3.83M Buy
24,978
+4,184
+20% +$639K 0.34% 53
2022
Q1
$3.37M Buy
20,794
+3,664
+21% +$532K 0.27% 61
2021
Q4
$2.32M Buy
17,130
+633
+4% +$74.8K 0.18% 79
2021
Q3
$1.78M Buy
16,497
+2,202
+15% +$252K 0.16% 90
2021
Q2
$1.61M Buy
14,295
+985
+7% +$111K 0.15% 84
2021
Q1
$1.44M Buy
13,310
+2,606
+24% +$279K 0.15% 85
2020
Q4
$1.15M Buy
10,704
+566
+6% +$54.4K 0.13% 93
2020
Q3
$888K Buy
10,138
+1,177
+13% +$111K 0.11% 100
2020
Q2
$880K Buy
8,961
+2,304
+35% +$203K 0.13% 84
2020
Q1
$507K Buy
6,657
+1,377
+26% +$117K 0.09% 119
2019
Q4
$467K Buy
5,280
+499
+10% +$41.4K 0.07% 139
2019
Q3
$362K Buy
4,781
+678
+17% +$46.5K 0.06% 170
2019
Q2
$298K Buy
4,103
+434
+12% +$34.1K 0.05% 188
2019
Q1
$296K Buy
3,669
+531
+17% +$43.4K 0.05% 184
2018
Q4
$289K Buy
3,138
+428
+16% +$37.6K 0.06% 188
2018
Q3
$256K Sell
2,710
-1,172
-30% -$111K 0.04% 205
2018
Q2
$360K Sell
3,882
-2,033
-34% -$199K 0.07% 187
2018
Q1
$560K Sell
5,915
-3,276
-36% -$360K 0.1% 167
2017
Q4
$889K Sell
9,191
-3,386
-27% -$319K 0.13% 161
2017
Q3
$1.12M Sell
12,577
-3,973
-24% -$302K 0.17% 135
2017
Q2
$1.2M Sell
16,550
-5,799
-26% -$390K 0.17% 138
2017
Q1
$1.46M Sell
22,349
-7,044
-24% -$443K 0.19% 128
2016
Q4
$1.84M Sell
29,393
-11,074
-27% -$676K 0.21% 99
2016
Q3
$2.55M Sell
40,467
-5,758
-12% -$373K 0.28% 85
2016
Q2
$2.86M Sell
46,225
-1,683
-4% -$103K 0.29% 84
2016
Q1
$2.74M Buy
47,908
+546
+1% +$30.4K 0.28% 88
2015
Q4
$2.81M Sell
47,362
-7,911
-14% -$456K 0.31% 85
2015
Q3
$3.01M Buy
55,273
+584
+1% +$38K 0.31% 80
2015
Q2
$3.67M Sell
54,689
-5,859
-10% -$382K 0.36% 73
2015
Q1
$3.54M Sell
60,548
-9,478
-14% -$573K 0.33% 77
2014
Q4
$4.58M Sell
70,026
-24,431
-26% -$1.54M 0.4% 65
2014
Q3
$5.46M Sell
94,457
-3,687
-4% -$205K 0.4% 65
2014
Q2
$5.54M Sell
98,144
-8,980
-8% -$471K 0.38% 68
2014
Q1
$5.51M Sell
107,124
-7,437
-6% -$376K 0.36% 68
2013
Q4
$6.05M Sell
114,561
-7,064
-6% -$347K 0.38% 64
2013
Q3
$5.44M Sell
121,625
-6,893
-5% -$306K 0.35% 70
2013
Q2
$5.31M Buy
+128,518
New +$5.62M 0.34% 68

Other funds holding ABBV

Tokio Marine Asset Management's ABBV Position: Q2 2026 in Review

Tokio Marine Asset Management increased its AbbVie (ABBV) stake by 5% in Q2 2026, buying an estimated $679K and bringing the position to 65,800 shares worth $16.6M. The position accounts for 0.51% of the portfolio, ranked #35.

Tokio Marine Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tokio Marine Asset Management held 65,800 shares of AbbVie worth $16.6M as of Q2 2026.
  • Tokio Marine Asset Management bought 3,154 AbbVie shares in Q2 2026, an estimated $679K.
  • AbbVie made up 0.51% of Tokio Marine Asset Management's portfolio in Q2 2026, its #35 holding.
  • Tokio Marine Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.